Literature DB >> 24527831

Tissue-engineered intervertebral discs: MRI results and histology in the rodent spine.

Peter Grunert1, Harry H Gebhard, Robby D Bowles, Andrew R James, Hollis G Potter, Michael Macielak, Katherine D Hudson, Marjan Alimi, Douglas J Ballon, Eric Aronowitz, Apostolos John Tsiouris, Lawrence J Bonassar, Roger Härtl.   

Abstract

OBJECT: Tissue-engineered intervertebral discs (TE-IVDs) represent a new experimental approach for the treatment of degenerative disc disease. Compared with mechanical implants, TE-IVDs may better mimic the properties of native discs. The authors conducted a study to evaluate the outcome of TE-IVDs implanted into the rat-tail spine using radiological parameters and histology.
METHODS: Tissue-engineered intervertebral discs consist of a distinct nucleus pulposus (NP) and anulus fibrosus (AF) that are engineered in vitro from sheep IVD chondrocytes. In 10 athymic rats a discectomy in the caudal spine was performed. The discs were replaced with TE-IVDs. Animals were kept alive for 8 months and were killed for histological evaluation. At 1, 5, and 8 months, MR images were obtained; T1-weighted sequences were used for disc height measurements, and T2-weighted sequences were used for morphological analysis. Quantitative T2 relaxation time analysis was used to assess the water content and T1ρ-relaxation time to assess the proteoglycan content of TE-IVDs.
RESULTS: Disc height of the transplanted segments remained constant between 68% and 74% of healthy discs. Examination of TE-IVDs on MR images revealed morphology similar to that of native discs. T2-relaxation time did not differ between implanted and healthy discs, indicating similar water content of the NP tissue. The size of the NP decreased in TE-IVDs. Proteoglycan content in the NP was lower than it was in control discs. Ossification of the implanted segment was not observed. Histological examination revealed an AF consisting of an organized parallel-aligned fiber structure. The NP matrix appeared amorphous and contained cells that resembled chondrocytes.
CONCLUSIONS: The TE-IVDs remained viable over 8 months in vivo and maintained a structure similar to that of native discs. Tissue-engineered intervertebral discs should be explored further as an option for the potential treatment of degenerative disc disease.

Entities:  

Mesh:

Year:  2014        PMID: 24527831     DOI: 10.3171/2013.12.SPINE13112

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  6 in total

1.  In-vivo T2-relaxation times of asymptomatic cervical intervertebral discs.

Authors:  Sean J Driscoll; Weiye Zhong; Martin Torriani; Haiqing Mao; Kirkham B Wood; Thomas D Cha; Guoan Li
Journal:  Skeletal Radiol       Date:  2015-12-07       Impact factor: 2.199

2.  Cervical total disc replacement is superior to anterior cervical decompression and fusion: a meta-analysis of prospective randomized controlled trials.

Authors:  Yujie Zhang; Chengzhen Liang; Yiqing Tao; Xiaopeng Zhou; Hao Li; Fangcai Li; Qixin Chen
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

3.  Dysfunctional microcirculation of the lumbar vertebral marrow prior to the bone loss and intervertebral discal degeneration.

Authors:  Lin Ou-Yang; Guang-ming Lu
Journal:  Spine (Phila Pa 1976)       Date:  2015-05-15       Impact factor: 3.468

4.  Decrease with aging of the microcirculatory function of the lumbar vertebral marrow preceding the loss of bone material density and the onset of intervertebral discal degeneration: A study about the potential cause.

Authors:  Lin Ou-Yang; Guang-Ming Lu
Journal:  Chronic Dis Transl Med       Date:  2015-06-23

5.  Degenerative changes of the canine cervical spine after discectomy procedures, an in vivo study.

Authors:  Peter Grunert; Yu Moriguchi; Brian P Grossbard; Rodolfo J Ricart Arbona; Lawrence J Bonassar; Roger Härtl
Journal:  BMC Vet Res       Date:  2017-06-23       Impact factor: 2.741

6.  Total disc replacement using tissue-engineered intervertebral discs in the canine cervical spine.

Authors:  Yu Moriguchi; Jorge Mojica-Santiago; Peter Grunert; Brenton Pennicooke; Connor Berlin; Thamina Khair; Rodrigo Navarro-Ramirez; Rodolfo J Ricart Arbona; Joseph Nguyen; Roger Härtl; Lawrence J Bonassar
Journal:  PLoS One       Date:  2017-10-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.